OCPWS
INTS icon

One Charles Private Wealth Services’s Intensity Therapeutics INTS Stock Holding History

One Charles Private Wealth Services’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,272
Closed -$13K – 170
2025
Q4 		$13K Hold
1,272
– – ﹤0.01% 171
2025
Q3 		$7.72K Hold
1,272
– – ﹤0.01% 167
2025
Q2 		$9.76K Hold
1,272
– – ﹤0.01% 163
2025
Q1 		$62.6K Hold
1,272
– – 0.02% 144
2024
Q4 		$56K Hold
1,272
– – 0.02% 153
2024
Q3 		$121K Hold
1,272
– – 0.05% 150
2024
Q2 		$156K Hold
1,272
– – 0.06% 146
2024
Q1 		$165K Buy
+1,272
New +$152K 0.07% 142

Other funds holding INTS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.18B AUM 18.43% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

One Charles Private Wealth Services's INTS Position: Q1 2026 in Review

One Charles Private Wealth Services sold out of Intensity Therapeutics (INTS) in Q1 2026, closing a stake of 1,272 shares — an estimated $13K sold.

One Charles Private Wealth Services first reported a position in INTS in Q1 2024 and held it in 8 quarters. The position peaked at $165K in Q1 2024. 13 funds tracked by Wall St. Rank hold INTS as of Q1 2026.

  • One Charles Private Wealth Services reported no remaining Intensity Therapeutics position as of Q1 2026 after selling out during the quarter.
  • One Charles Private Wealth Services sold 1,272 Intensity Therapeutics shares in Q1 2026, an estimated $13K.
  • One Charles Private Wealth Services first reported a position in Intensity Therapeutics in Q1 2024 and held it in 8 quarters.
  • One Charles Private Wealth Services's Intensity Therapeutics position peaked at $165K in Q1 2024.
  • 13 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q1 2026.

Based on One Charles Private Wealth Services's 13F filing for Q1 2026, filed 7 May 2026.